Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. TELECOM Microsoft and MCI announce a new venture to offer Internet-based phone service.
Op-Eds
Enviros Exaggerated Montreal Summit
A world historical event occurred in <?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />Montreal in the hours before dawn on December 10. What? …
Op-Eds
Lives for Votes
December 15, 2005 — With his record, a call from state Attorney General Eliot Spitzer is enough to give even innocent defendants…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. INTERNET People around the globe celebrate 15 years of the World Wide Web.
Op-Eds
Good Drugs, Bad Rap
These are turbulent times for the pharmaceutical industry and for its regulator, the FDA. Lately, both have focused increasingly on issues of safety.
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. REGULATORY COSTS President Bush speaks about controlling the costs imposed on business by regulatory expenses. CEI…